Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 2
1948 2
1951 7
1952 2
1953 6
1954 5
1955 11
1956 6
1957 6
1958 5
1959 5
1960 6
1961 7
1962 7
1963 1
1964 4
1965 2
1966 1
1967 2
1970 1
1971 2
1972 34
1973 63
1974 55
1975 67
1976 101
1977 60
1978 87
1979 93
1980 73
1981 95
1982 121
1983 91
1984 134
1985 112
1986 126
1987 123
1988 127
1989 112
1990 121
1991 147
1992 114
1993 107
1994 122
1995 121
1996 125
1997 114
1998 105
1999 117
2000 156
2001 105
2002 103
2003 111
2004 89
2005 104
2006 108
2007 86
2008 101
2009 79
2010 95
2011 92
2012 92
2013 84
2014 85
2015 81
2016 85
2017 75
2018 85
2019 69
2020 56
2021 63
2022 59
2023 77
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

4,894 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics of the carmustine implant.
Fleming AB, Saltzman WM. Fleming AB, et al. Clin Pharmacokinet. 2002;41(6):403-19. doi: 10.2165/00003088-200241060-00002. Clin Pharmacokinet. 2002. PMID: 12074689 Review.
In addition, studies to characterise the degradation of the polymer matrix, the release kinetics of carmustine and the metabolic fate of the drug and polymer degradation products have been conducted both in vitro and in vivo. GLIADEL wafers have been shown to release ca …
In addition, studies to characterise the degradation of the polymer matrix, the release kinetics of carmustine and the metabolic fate …
Efficacy and safety of carmustine wafers in the treatment of glioblastoma multiforme: a systematic review.
Zhang YD, Dai RY, Chen Z, Zhang YH, He XZ, Zhou J. Zhang YD, et al. Turk Neurosurg. 2014;24(5):639-45. doi: 10.5137/1019-5149.JTN.8878-13.1. Turk Neurosurg. 2014. PMID: 25269031 Free article. Review.
Implantation of carmustine wafers did not significantly improve progression-free survival. Carmustine wafers did not increase adverse effects. This systematic review suggests that carmustine wafers have demonstrated promise as an effective and tolerable treat …
Implantation of carmustine wafers did not significantly improve progression-free survival. Carmustine wafers did not increase …
Modeling mass transfer from carmustine-loaded polymeric implants for malignant gliomas.
Pereira DY, Yip AT, Lee BS, Kamei DT. Pereira DY, et al. J Lab Autom. 2014 Feb;19(1):19-34. doi: 10.1177/2211068213499157. Epub 2013 Aug 23. J Lab Autom. 2014. PMID: 23975389 Review.
Rather, pharmacokinetic studies in animals and associated modeling have indicated the capability of carmustine to be delivered in high concentrations within millimeters from the implant site over approximately 5 days. Mathematical models have indicated that diffusion has a …
Rather, pharmacokinetic studies in animals and associated modeling have indicated the capability of carmustine to be delivered in hig …
Carmustine (BiCNU).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1978 Sep 8;20(18):79-80. Med Lett Drugs Ther. 1978. PMID: 692493 No abstract available.
BCNU (carmustine).
Burnham N, Betcher DL. Burnham N, et al. J Assoc Pediatr Oncol Nurses. 1989;6(1):23-5. doi: 10.1177/104345428900600109. J Assoc Pediatr Oncol Nurses. 1989. PMID: 2921741 No abstract available.
H2-antagonists and carmustine.
Dorr RT, Soble MJ. Dorr RT, et al. J Cancer Res Clin Oncol. 1989;115(1):41-6. doi: 10.1007/BF00391598. J Cancer Res Clin Oncol. 1989. PMID: 2564000
The highly metabolized nitrosourea carmustine (BCNU) is an anticancer agent which alkylates DNA and is metabolized to both active and inactive species by cytochrome P-450 enzymes. ...
The highly metabolized nitrosourea carmustine (BCNU) is an anticancer agent which alkylates DNA and is metabolized to both active and …
Carmustine and myelodysplasia.
Lichtman SM, Schulman P. Lichtman SM, et al. Ann Intern Med. 1985 Dec;103(6 ( Pt 1)):964. doi: 10.7326/0003-4819-103-6-964_3. Ann Intern Med. 1985. PMID: 4062111 No abstract available.
How safe are carmustine wafers?
Grangeon L, Ferracci FX, Fetter D, Maltete D, Langlois O, Gilard V. Grangeon L, et al. Rev Neurol (Paris). 2018 May;174(5):346-351. doi: 10.1016/j.neurol.2017.09.011. Epub 2018 Apr 25. Rev Neurol (Paris). 2018. PMID: 29703443 No abstract available.
Carmustine and the lungs .
Schmitz N, Diehl V. Schmitz N, et al. Lancet. 1997 Jun 14;349(9067):1712-3. doi: 10.1016/S0140-6736(05)62951-0. Lancet. 1997. PMID: 9193378 No abstract available.
4,894 results

Searches related to "carmustine"